Mousavi Seyedeh Maryam, Karimi-Haghighi Saeideh, Chavoshinezhad Sara, Pandamooz Sareh, Belém-Filho Ivaldo Jesus Almeida, Keshavarz Somaye, Bayat Mahnaz, Hooshmandi Etrat, Rahimi Jaberi Abbas, Salehi Mohammad Saied, Borhani-Haghighi Afshin
Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz.
Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj.
Neuroreport. 2022 Sep 7;33(13):561-568. doi: 10.1097/WNR.0000000000001816. Epub 2022 Aug 3.
The middle cerebral artery occlusion (MCAO) model was introduced more than 3 decades ago to simulate human stroke. Till now, it is the most common platform to investigate stroke-induced pathological changes as well as to discover new drugs and treatments. Induction of general anesthesia is mandatory to induce this model, and different laboratories are using various anesthetic drugs, which might affect MCAO results. Therefore, the present study was designed to compare the impacts of several widely used anesthetic regimens on the MCAO outcomes. Here, adult male rats were anesthetized by isoflurane inhalation, intraperitoneal injection of chloral hydrate (CH), intraperitoneal injection of ketamine-xylazine, or subcutaneous administration of ketamine-xylazine, then subjected to 30 min MCAO. Survival rate, body weight change, infarct size, as well as cognitive and neurological performance were evaluated up to 3 days after the surgery. Our findings revealed CH caused the highest, whereas subcutaneous ketamine-xylazine led to the lowest mortality. Meanwhile, there were no significant differences in the body weight loss, infarct size, cognitive impairments, and neurological deficits among the experimental groups. Based on the current results, we proposed that subcutaneous injection of ketamine-xylazine could be an effective anesthetic regimen in the rat model of MCAO with several advantages such as low mortality, cost-effectiveness, safety, ease of administration, and not requiring specialized equipment.
大脑中动脉闭塞(MCAO)模型于30多年前被引入以模拟人类中风。迄今为止,它是研究中风诱导的病理变化以及发现新药和治疗方法的最常用平台。诱导该模型必须进行全身麻醉,不同实验室使用各种麻醉药物,这可能会影响MCAO结果。因此,本研究旨在比较几种广泛使用的麻醉方案对MCAO结果的影响。在此,成年雄性大鼠通过吸入异氟醚、腹腔注射水合氯醛(CH)、腹腔注射氯胺酮-赛拉嗪或皮下注射氯胺酮-赛拉嗪进行麻醉,然后进行30分钟的MCAO。在手术后3天内评估存活率、体重变化、梗死面积以及认知和神经功能。我们的研究结果显示,CH导致的死亡率最高,而皮下注射氯胺酮-赛拉嗪导致的死亡率最低。同时,实验组之间在体重减轻、梗死面积、认知障碍和神经功能缺损方面没有显著差异。基于目前的结果,我们提出皮下注射氯胺酮-赛拉嗪可能是MCAO大鼠模型中的一种有效麻醉方案,具有低死亡率、成本效益高、安全、易于给药且不需要专门设备等优点。